Guerbet SA (0ELV.L)

EUR 19.98

(-0.35%)

EBITDA Summary of Guerbet SA

  • Guerbet SA's latest annual EBITDA in 2023 was 90.09 Million EUR , down -1.26% from previous year.
  • Guerbet SA's latest quarterly EBITDA in 2024 Q2 was 60.41 Million EUR , down 0.0% from previous quarter.
  • Guerbet SA reported an annual EBITDA of 32.28 Million EUR in 2022, down -1.6% from previous year.
  • Guerbet SA reported an annual EBITDA of 85.09 Million EUR in 2021, down -2.0% from previous year.
  • Guerbet SA reported a quarterly EBITDA of N/A for 2023 FY, up 2.59% from previous quarter.
  • Guerbet SA reported a quarterly EBITDA of 40.64 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Guerbet SA (2023 - 2012)

Historical Annual EBITDA of Guerbet SA (2023 - 2012)

Year EBITDA EBITDA Growth
2023 90.09 Million EUR -1.26%
2022 32.28 Million EUR -1.6%
2021 85.09 Million EUR -2.0%
2020 94.62 Million EUR -15.28%
2019 111.63 Million EUR -1.76%
2018 114.51 Million EUR -1.51%
2017 106.28 Million EUR 8.72%
2016 103.14 Million EUR 24.28%
2015 90.42 Million EUR 36.98%
2014 62.37 Million EUR 26.31%
2013 49.38 Million EUR -0.33%
2012 49.54 Million EUR 0.0%

Peer EBITDA Comparison of Guerbet SA

Name EBITDA EBITDA Difference
Cegedim SA 95.25 Million EUR 5.414%
Nexus AG 53.43 Million EUR -68.617%
Bastide Le Confort Médical SA 110.32 Million EUR 18.337%
Revenio Group Oyj 30.09 Million EUR -199.415%
Drägerwerk AG & Co. KGaA 318.33 Million EUR 71.698%
Sartorius Aktiengesellschaft 811.2 Million EUR 88.894%
LNA Santé SA 144.63 Million EUR 37.709%
Siemens Healthineers AG 4.22 Billion EUR 97.868%
Medios AG 52.81 Million EUR -70.581%
Equasens Société anonyme 71.29 Million EUR -26.361%
Stratec SE 39.82 Million EUR -126.247%